Dysregulation of cancer-critical genes leads to mTOR hyperactivation, which in turn, increases the translation of pro-oncogenic proteins that directly affect cellular processes such as cell growth, migration, and de novo blood vessel formation [41]. The gene discussed is MTOR; the disease is cancer.